Target intelligence / Profile preview

BolA family member 2B (BOLA2B)

Target
BOLA2B
Molecular classification
Other (BolA family protein; not a classical receptor, enzyme, transporter, etc.), Possible transcription factor activity (helix-turn-helix motif for nucleic acid binding), Iron–sulfur (Fe–S) cluster assembly protein
01

Overview

BolA family member 2B (BOLA2B) is a protein-coding gene recently characterized through advanced human genome projects. It encodes a BolA family protein involved in maintaining normal cell shape, regulating cell division, and assembling iron–sulfur clusters crucial for cellular redox reactions and electron transport[1][3]. BOLA2B is expressed in both nuclear and cytoplasmic compartments and interacts with glutaredoxin proteins (GLRX3, GLRX5), contributing to iron metabolism and homeostasis. Pathologically, BOLA2B is highly expressed in various tumors (notably hepatocellular carcinoma and ovarian cancer), where it drives cancer progression through activation of mTORC1 and c-MYC signaling, and is associated with poorer prognoses. It may function as a transcription factor and participates in pathways regulating cell cycle (especially G2/M checkpoint), autophagy, and PI3K-AKT signaling[1][3]. Due to its role in tumor biology and iron metabolism, BOLA2B represents a novel candidate as a therapeutic target and biomarker for cancer, although no drugs currently target it directly. Note: Information about BOLA2B is rapidly evolving due to its recent discovery; details on clinical relevance or therapeutic targeting may change as research progresses[1][3].

Other names
BolA-like protein 2BOLA2BOLA2AMy016BolA-like protein 2 member BbolA homolog 2BbolA-like protein 2B
02

Biological functions

Cell morphology regulationCell divisionIron homeostasis (cofactor for iron–sulfur clusters and redox balance)Cell cycle regulation (induces G2/M cell-cycle arrest)Transcriptional regulation (possible DNA binding activity)Interaction with mTOR, autophagy, and PI3K-AKT pathways
03

Disease associations

Cancer (high expression linked to poor prognosis and tumor progression, e.g., ovarian and liver cancer)Iron dysregulation/iron deficiency anemiaPossible involvement in cell proliferation disease states
04

Biomarkers

Potential biomarker for poor prognosis in cancers (especially liver and ovarian)

Beyond the preview

Go deeper on BolA family member 2B (BOLA2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BolA family member 2B (BOLA2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call